AR117835A1 - Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismo - Google Patents
Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismoInfo
- Publication number
- AR117835A1 AR117835A1 ARP200100125A ARP200100125A AR117835A1 AR 117835 A1 AR117835 A1 AR 117835A1 AR P200100125 A ARP200100125 A AR P200100125A AR P200100125 A ARP200100125 A AR P200100125A AR 117835 A1 AR117835 A1 AR 117835A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- purification
- pcta
- binder
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1900432A FR3091873B1 (fr) | 2019-01-17 | 2019-01-17 | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117835A1 true AR117835A1 (es) | 2021-08-25 |
Family
ID=67001953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP200100125A AR117835A1 (es) | 2019-01-17 | 2020-01-17 | Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismo |
Country Status (28)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020030618A1 (en) | 2018-08-06 | 2020-02-13 | Bracco Imaging Spa | Gadolinium bearing pcta-based contrast agents |
| FR3091873B1 (fr) * | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification |
| FR3091872B1 (fr) * | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese |
| US20230339945A1 (en) * | 2020-07-17 | 2023-10-26 | Guerbet | Method for preparing a chelating ligand derived from pcta |
| EP4222861A4 (en) * | 2020-10-02 | 2024-10-02 | Eagle Harbor Technologies, Inc. | IONIC CURRENT DROP COMPENSATION |
| WO2022165424A1 (en) | 2021-02-01 | 2022-08-04 | Inventure, LLC | Synthesis methods and compositions of low intermediate and low dichelate intermediate contrast agents |
| KR102845061B1 (ko) * | 2022-09-01 | 2025-08-13 | 주식회사 테라노큐어 | 신규한 화합물 및 이를 포함하는 mri 조영제 |
| JP7895667B2 (ja) * | 2022-09-01 | 2026-07-28 | テラノキュア カンパニー リミテッド | 新規化合物、およびこれを含むｍｒｉ造影剤 |
| WO2026027591A1 (en) | 2024-07-31 | 2026-02-05 | Bracco Imaging Spa | Synthesis of an intermediate of a gadolinium-based contrast agent |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4647447A (en) | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
| DE3640708C2 (de) | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
| DE4001655A1 (de) | 1990-01-18 | 1991-07-25 | Schering Ag | 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| JPH04154729A (ja) | 1990-10-16 | 1992-05-27 | Nippon Mejifuijitsukusu Kk | 磁気共鳴造影剤 |
| IT1292128B1 (it) | 1997-06-11 | 1999-01-25 | Bracco Spa | Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici |
| EP0992245A1 (en) | 1998-09-16 | 2000-04-12 | Goldham Bioglan Pharma GmbH | Radio-contrast agents |
| FR2793795B1 (fr) * | 1999-05-21 | 2001-08-03 | Guerbet Sa | Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale |
| FR2794744B1 (fr) | 1999-06-09 | 2001-09-21 | Guerbet Sa | Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale |
| FR2891830B1 (fr) * | 2005-10-07 | 2011-06-24 | Guerbet Sa | Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale |
| US20090208421A1 (en) * | 2008-02-19 | 2009-08-20 | Dominique Meyer | Process for preparing a pharmaceutical formulation of contrast agents |
| US8119817B2 (en) * | 2009-09-29 | 2012-02-21 | Degussa-Huels Ag | Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline |
| EP2786768A1 (en) | 2013-04-04 | 2014-10-08 | Agfa Healthcare | Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide |
| KR102231121B1 (ko) * | 2013-04-26 | 2021-03-23 | 게르브 | 조영제 제형 및 이와 관련된 제조 방법 |
| CN104188957B (zh) * | 2014-05-28 | 2017-04-26 | 中国中医科学院西苑医院 | 一种防治再狭窄的药物及其制备和使用方法 |
| US11155519B2 (en) * | 2017-04-28 | 2021-10-26 | Otsuka Pharmaceutical Factory, Inc. | Method for manufacturing diastereomer of citric acid derivative |
| WO2020030618A1 (en) | 2018-08-06 | 2020-02-13 | Bracco Imaging Spa | Gadolinium bearing pcta-based contrast agents |
| FR3091873B1 (fr) | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification |
| FR3091872B1 (fr) | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese |
-
2019
- 2019-01-17 FR FR1900432A patent/FR3091873B1/fr active Active
-
2020
- 2020-01-17 TW TW109101779A patent/TWI811518B/zh active
- 2020-01-17 CN CN202080009625.8A patent/CN113646308B/zh active Active
- 2020-01-17 PT PT207017096T patent/PT3902800T/pt unknown
- 2020-01-17 HU HUE21190088A patent/HUE062554T2/hu unknown
- 2020-01-17 CN CN202411689939.3A patent/CN119552163A/zh active Pending
- 2020-01-17 PH PH1/2021/551725A patent/PH12021551725A1/en unknown
- 2020-01-17 BR BR112021014006-9A patent/BR112021014006B1/pt active IP Right Grant
- 2020-01-17 MX MX2021008651A patent/MX2021008651A/es unknown
- 2020-01-17 CA CA3126268A patent/CA3126268C/fr active Active
- 2020-01-17 RS RS20230530A patent/RS64334B1/sr unknown
- 2020-01-17 HR HRP20221402TT patent/HRP20221402T1/hr unknown
- 2020-01-17 PT PT211900881T patent/PT3943493T/pt unknown
- 2020-01-17 KR KR1020217036451A patent/KR102502862B1/ko active Active
- 2020-01-17 MA MA055389A patent/MA55389A/fr unknown
- 2020-01-17 SG SG11202107779SA patent/SG11202107779SA/en unknown
- 2020-01-17 EP EP20701709.6A patent/EP3902800B1/fr active Active
- 2020-01-17 DK DK21190088.1T patent/DK3943493T3/da active
- 2020-01-17 AU AU2020208794A patent/AU2020208794B2/en active Active
- 2020-01-17 JP JP2021541202A patent/JP7071596B2/ja active Active
- 2020-01-17 HU HUE20701709A patent/HUE060343T2/hu unknown
- 2020-01-17 WO PCT/EP2020/051153 patent/WO2020148436A1/fr not_active Ceased
- 2020-01-17 ES ES20701709T patent/ES2930136T3/es active Active
- 2020-01-17 KR KR1020217025766A patent/KR102438394B1/ko active Active
- 2020-01-17 PL PL21190088.1T patent/PL3943493T3/pl unknown
- 2020-01-17 ES ES21190088T patent/ES2950118T3/es active Active
- 2020-01-17 HR HRP20230678TT patent/HRP20230678T1/hr unknown
- 2020-01-17 EP EP21190088.1A patent/EP3943493B1/fr active Active
- 2020-01-17 IL IL284884A patent/IL284884B2/en unknown
- 2020-01-17 MA MA054626A patent/MA54626A/fr unknown
- 2020-01-17 US US17/423,638 patent/US11590246B2/en active Active
- 2020-01-17 DK DK20701709.6T patent/DK3902800T3/da active
- 2020-01-17 AR ARP200100125A patent/AR117835A1/es unknown
- 2020-01-17 PL PL20701709.6T patent/PL3902800T3/pl unknown
- 2020-01-17 FI FIEP21190088.1T patent/FI3943493T3/fi active
- 2020-01-17 CN CN202111049738.3A patent/CN113735854B/zh active Active
-
2021
- 2021-07-14 CL CL2021001868A patent/CL2021001868A1/es unknown
- 2021-07-15 ZA ZA2021/04994A patent/ZA202104994B/en unknown
- 2021-07-15 CO CONC2021/0009261A patent/CO2021009261A2/es unknown
- 2021-10-25 JP JP2021173867A patent/JP7321230B2/ja active Active
-
2023
- 2023-01-16 US US18/154,894 patent/US12064487B2/en active Active
-
2024
- 2024-07-09 US US18/766,792 patent/US20240358863A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021009261A2 (es) | Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de preparación y de purificación | |
| CL2024000373A1 (es) | Compuesto inductor de la degradación de plk1 novedoso | |
| PE20220134A1 (es) | Compuestos de pirrolidina | |
| UY39197A (es) | Mezclas y composiciones que comprenden 5-fluoro-4-imino-3- metil-1-tosil-3,4-dihidropirimidin-2-ona, y métodos de uso de las mismas | |
| MX2020013853A (es) | Compuestos innovadores. | |
| CO2021009253A2 (es) | Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de síntesis | |
| CO2019011604A2 (es) | Compuestos inhibidores de vmat2, composiciones y métodos relativos a los mismos | |
| MX2017010062A (es) | [9,10-dimetoxi-3-(2-metilpropil)-1h,2h,3h,4h,6h,7h,11bh-pirido-[2 ,1-a]isoquinolin-2-il]metanol y compuestos, composiciones y metodos relacionados con los mismos. | |
| CU24265B1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, útiles en el tratamiento del cáncer | |
| AR093244A1 (es) | Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2 | |
| AR123424A1 (es) | Nuevos compuestos heterocíclicos | |
| CL2021002263A1 (es) | Compuestos antibacterianos (solicitud divisional 202001147) | |
| MX380751B (es) | Ingrediente perfumante verde de lirio del valle. | |
| ECSP21088111A (es) | Analogos de 3(5metil1,3tiazol2il)n{(1r)1[2(trifluormetil)pirimidin5il]etil}benzamida | |
| MX2020004930A (es) | Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido). | |
| UY38941A (es) | Nuevas sulfiliminas o sulfoximinas que contienen compuestos heterocíclicos fungicidas | |
| AR104731A1 (es) | Benzamidas sustituidas y métodos para utilizarlas | |
| MX2023015490A (es) | Inhibidores de las transglutaminasas. | |
| CL2023003921A1 (es) | Inhibidores de transglutaminasas | |
| ECSP21011232A (es) | Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende | |
| MX2020012829A (es) | Compuestos de ciclopentanona. | |
| MX2022002941A (es) | Cristal de derivado de 1,3,5-triazina o solvato del mismo y metodo para producir el mismo. | |
| ECSP24007534A (es) | Inhibidores de transglutaminasas | |
| MX2021012544A (es) | Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de enfermedades renales. | |
| AR106516A1 (es) | PROCESO PARA LA PREPARACIÓN DE 17b-HIDROXI-DES-A-ANDROST-9,10-EN-5-ONA |